AZIYO BIOLOGICS(AZYO) - 2024 Q4 - Annual Results

Exhibit 99.1 Elutia Announces Fourth Quarter and Full Year 2024 Financial Results: Strong Demand for EluPro™ in Pilot Launch Sets the Stage for Full Commercial Roll-Out - Overall BioEnvelope sales up 18%, with same-center sales increasing 65% following EluPro commercialization - SILVER SPRING, Md., March 6, 2025 — Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today provided a business update and financial results for the fourth quarter and full yea ...